tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid

C90H78F12Ir4N20O4-3 — CID 159361682

IUPACtetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid
SMILESCC(O)CC(C)O.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.O=C(O)c1ccccn1.[Ir+3].[Ir].[Ir].[Ir].[c-]1ccccc1-c1nc(-c2ccccc2)n[n-]1.c1cnn(C(n2cccn2)(n2cccn2)[n+]2ccc[n-]2)c1
InChIInChI=1S/C14H9N3.4C13H10F3N2.C13H12N8.C6H5NO2.C5H12O2.4Ir/c1-3-7-11(8-4-1)13-15-14(17-16-13)12-9-5-2-6-10-12;4*1-8-7-17-12(9(2)18-8)10-3-5-11(6-4-10)13(14,15)16;1-5-14-18(9-1)13(19-10-2-6-15-19,20-11-3-7-16-20)21-12-4-8-17-21;8-6(9)5-3-1-2-4-7-5;1-4(6)3-5(2)7;;;;/h1-9H;4*3,5-7H,1-2H3;1-12H;1-4H,(H,8,9);4-7H,3H2,1-2H3;;;;/q-2;4*-1;;;;;;;+3
InChIKeyLLKSOEARGUTOBK-UHFFFAOYSA-N
MW2500.59 g/mol
LogP17.53
Rot. Bonds13

About tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid

tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid (PubChem CID 159361682) has the molecular formula C90H78F12Ir4N20O4-3 and a molecular weight of 2500.59 g/mol. Its IUPAC name is tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid.

Molecular Properties

Compound Nametetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid
PubChem CID159361682
Molecular FormulaC90H78F12Ir4N20O4-3
Molecular Weight2500.59 g/mol
Exact Mass2502.49
IUPAC Nametetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid
SMILESCC(O)CC(C)O.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.O=C(O)c1ccccn1.[Ir+3].[Ir].[Ir].[Ir].[c-]1ccccc1-c1nc(-c2ccccc2)n[n-]1.c1cnn(C(n2cccn2)(n2cccn2)[n+]2ccc[n-]2)c1
InChIInChI=1S/C14H9N3.4C13H10F3N2.C13H12N8.C6H5NO2.C5H12O2.4Ir/c1-3-7-11(8-4-1)13-15-14(17-16-13)12-9-5-2-6-10-12;4*1-8-7-17-12(9(2)18-8)10-3-5-11(6-4-10)13(14,15)16;1-5-14-18(9-1)13(19-10-2-6-15-19,20-11-3-7-16-20)21-12-4-8-17-21;8-6(9)5-3-1-2-4-7-5;1-4(6)3-5(2)7;;;;/h1-9H;4*3,5-7H,1-2H3;1-12H;1-4H,(H,8,9);4-7H,3H2,1-2H3;;;;/q-2;4*-1;;;;;;;+3
InChIKeyLLKSOEARGUTOBK-UHFFFAOYSA-N
XLogP17.53
TPSA305.09 Ų
H-Bond Donors3
H-Bond Acceptors20
Rotatable Bonds13
Heavy Atoms130
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002500.59
LogP ≤ 517.53
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}

Analyze tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid?
The IUPAC name of tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid (CID 159361682) is tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid.
What is the SMILES notation for tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid?
The canonical SMILES for tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid is CC(O)CC(C)O.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.Cc1cnc(-c2[c-]cc(C(F)(F)F)cc2)c(C)n1.O=C(O)c1ccccn1.[Ir+3].[Ir].[Ir].[Ir].[c-]1ccccc1-c1nc(-c2ccccc2)n[n-]1.c1cnn(C(n2cccn2)(n2cccn2)[n+]2ccc[n-]2)c1.
What is the InChIKey of tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid?
The InChIKey is LLKSOEARGUTOBK-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H9N3.4C13H10F3N2.C13H12N8.C6H5NO2.C5H12O2.4Ir/c1-3-7-11(8-4-1)13-15-14(17-16-13)12-9-5-2-6-10-12;4*1-8-7-17-12(9(2)18-8)10-3-5-11(6-4-10)13(14,15)16;1-5-14-18(9-1)13(19-10-2-6-15-19,20-11-3-7-16-20)21-12-4-8-17-21;8-6(9)5-3-1-2-4-7-5;1-4(6)3-5(2)7;;;;/h1-9H;4*3,5-7H,1-2H3;1-12H;1-4H,(H,8,9);4-7H,3H2,1-2H3;;;;/q-2;4*-1;;;;;;;+3.
What are the key properties of tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid?
tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid has a molecular weight of 2500.59 g/mol, XLogP of 17.53, 13 rotatable bonds, 3 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for tetrakis(3,5-dimethyl-2-[4-(trifluoromethyl)benzene-6-id-1-yl]pyrazine);tris(iridium);iridium(3+);pentane-2,4-diol;3-phenyl-5-phenyl-2,4-diaza-1-azanidacyclopenta-2,4-diene;1-[pyrazol-2-ium-1-id-2-yl-di(pyrazol-1-yl)methyl]pyrazole;pyridine-2-carboxylic acid is sourced from PubChem (CID 159361682), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).